Results 121 to 130 of about 11,489 (193)

Cross-Priming of Cytotoxic T Cells Dictates Antigen Requisites for Modified Vaccinia Virus Ankara Vector Vaccines [PDF]

, 2007
Georg Gasteiger, Wolfgang Kastenmüller, Ronny Ljapoci, Gerd Sutter, Ingo Drexler   +4 more
openalex   +1 more source

Broad Immunogenicity of a Multigene, Multiclade HIV‐1 DNA Vaccine Boosted with Heterologous HIV‐1 Recombinant Modified Vaccinia Virus Ankara [PDF]

, 2008
Eric Sandström, Charlotta Nilsson, Bo Hejdeman, Andreas Bråve, Göran Bratt, Merlin L. Robb, Josephine H. Cox, Thomas C. VanCott, Mary Marovich, Richard Stout, Said Aboud, Muhammad Bakari, Kisali Pallangyo, Karl Ljungberg, Bernard Moss, Patricia L. Earl, Nelson L. Michael, Deborah L. Birx, Fred Mhalu, Britta Wahrén, Gunnel Biberfeld   +20 more
openalex   +1 more source

COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice. [PDF]

J Virol, 2021
García-Arriaza J, Garaigorta U, Pérez P, Lázaro-Frías A, Zamora C, Gastaminza P, Del Fresno C, Casasnovas JM, Sorzano CÓS, Sancho D, Esteban M.   +10 more
europepmc   +1 more source

Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant Δ ureC hly ⁺ Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis [PDF]

, 2008
Elma Tchilian, Christiane Desel, Emily Forbes, Silke Bandermann, Clare R. Sander, Adrian V. S. Hill, Helen McShane, Stefan H. E. Kaufmann   +7 more
openalex   +1 more source

Postexposure Immunization with Modified Vaccinia Virus Ankara or Conventional Lister Vaccine Provides Solid Protection in a Murine Model of Human Smallpox [PDF]

, 2008
Nir Paran, Yasemin Suezer, Shlomo Lustig, Tomer Israely, Astrid Schwantes, Sharon Melamed, L. J. Katz, Thomas G. Preuß, Kay-Martin Hanschmann, Ulrich Kalinke, Noam Erez, Reuven Levin, Baruch Velan, Johannes Löwer, Avigdor Shafferman, Gerd Sutter   +15 more
openalex   +1 more source

Neutralization Assay Using a Modified Vaccinia Virus Ankara Vector Expressing the Green Fluorescent Protein Is a High-Throughput Method To Monitor the Humoral Immune Response against Vaccinia Virus

, 2004
Antonio Cosma, Silja Bühler, Rashmi Nagaraj, Caroline Staib, Anna‐Lena Hammarin, Britta Wahrén, F. D. Goebel, Volker Erfle, Gerd Sutter   +8 more
openalex   +1 more source

Design and construction of a fast synthetic modified vaccinia virus Ankara reverse genetics system for advancing vaccine development. [PDF]

Front Microbiol
Gao Z, Wang B, Liu T, Zhao Z, Xu J, Zhao X, Zhang Z, Jia Z, Yang Y, Wu S, Chen W, Hou L.   +11 more
europepmc   +1 more source

Modulation of Cell Surface Receptor Expression by Modified Vaccinia Virus Ankara in Leukocytes of Healthy and HIV-Infected Individuals. [PDF]

Front Immunol, 2020
Leite Pereira A, Jouhault Q, Marcos Lopez E, Cosma A, Lambotte O, Le Grand R, Lehmann MH, Tchitchek N.   +7 more
europepmc   +1 more source

Prime/boost immunotherapy of HPV16-induced tumors with E7 protein delivered by Bordetella adenylate cyclase and modified vaccinia virus Ankara

, 2005
Jana Macková, Jana Stasikova, L Kutinová, Jiří Mašín, Petr Hainz, Marcela Simsova, Pavel Gabriel, Peter Šebo, Šárka Němečková   +8 more
openalex   +2 more sources

Modified Vaccinia Virus Ankara Triggers Chemotaxis of Monocytes and Early Respiratory Immigration of Leukocytes by Induction of CCL2 Expression [PDF]

, 2009
Michael H. Lehmann, Wolfgang Kastenmüller, Judith D. Kandemir, Florian Brandt, Yasemin Suezer, Gerd Sutter   +5 more
openalex   +1 more source